EUVIMEDEUVIMED entdecken
Crossref

Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end‐stage liver disease

Rachel Todd iD, L Leonie van Leeuwen iD, Matthew Holzner iD, Leona Kim-Schluger iD, Maria Isabel Fiel iD, Daniel Puleston iD, Sander S Florman iD, M Zeeshan Akhtar iD

Artificial Organs · 2025

DOI: 10.1111/aor.14905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Rachel Todd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, New York, USA. Hauptthemen laut MEDLINE: Perfusion, Liver, Liver Transplantation, Organ Preservation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: American Society of Transplant Surgeons.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Normothermic machine perfusion (NMP) is a technique for donor liver preservation and assessment in transplantation. NMP has gained momentum recently by enabling safer use of higher risk organs via organ viability assessment. It also offers a platform for investigating ex vivo organ biology.

Methods

In this exploratory study, we completed a complex vascular reconstruction of explanted, diseased livers from patients undergoing transplantation and then perfused them normothermically on a closed perfusion circuit. We compared these livers to non‐diseased donor livers via perfusate samples collected during perfusion.

Results

Five hepatectomized grafts and eight donor livers were perfused for 1 h or longer. Four hepatectomized livers cleared lactate, and all consumed glucose; all control livers cleared lactate, and seven utilized glucose. Significantly higher portal vein flows were achieved in the control group.

Conclusions

Our findings illustrate the feasibility of using closed‐circuit NMP as a platform to study hepatectomized organs, which could reshape the research landscape in mechanisms of disease and applied therapeutics for patients with end‐stage liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PerfusionLiverLiver TransplantationOrgan PreservationEnd Stage Liver DiseaseHumansMaleHepatectomyFemaleMiddle AgedGlucoseAdultLactic Acid

Stichwörter der Autor:innen

hepatectomyliver cirrhosisliver diseases physiopathologyorgan preservation

Substanzen

GlucoseLactic Acid

Autor:innen und Institutionen

  • Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, New York, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Rachel Todd, L Leonie van Leeuwen, Matthew Holzner, Leona Kim-Schluger, Maria Isabel Fiel, Daniel Puleston, Sander S Florman, M Zeeshan Akhtar

Förderung

  • American Society of Transplant Surgeons

Zitieren

APA

Todd, R., van Leeuwen, L. L., Holzner, M., Kim-Schluger, L., Fiel, M. I., Puleston, D., Florman, S. S., & Akhtar, M. Z. (2025). Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end‐stage liver disease. Artificial Organs. https://doi.org/10.1111/aor.14905

Vancouver

Todd R, van Leeuwen LL, Holzner M, Kim-Schluger L, Fiel MI, Puleston D, et al. Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end‐stage liver disease. Artificial Organs. 2025. doi:10.1111/aor.14905

BibTeX
@article{Todd2025,
  author = {Todd, Rachel and van Leeuwen, L Leonie and Holzner, Matthew and Kim-Schluger, Leona and Fiel, Maria Isabel and Puleston, Daniel and Florman, Sander S and Akhtar, M Zeeshan},
  title = {Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end‐stage liver disease},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.14905}
}
Kostenlos starten →